StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.51−0.03 (-2.27%)

Close on Nov 18, 2026Market cap $10.60MP/E –Yield –

Vyome revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Vyome's revenue for the twelve months ending Jun 30, 2026 was $129.72K, down 67.1% year over year. For fiscal 2025 it was $319.71K, up 24.4% from the year before. Over ten years it grew -22.4% a year on average. The highest annual figure on record is $13.60M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$319.71K+24.4%
FY2024Dec 31, 2024$256.94K-97.0%
FY2023Dec 31, 2023$8.68M-22.8%
FY2022Dec 31, 2022$11.24M-17.4%
FY2021Dec 31, 2021$13.60M+20.4%
FY2020Dec 31, 2020$11.30M+244.4%
FY2019Dec 31, 2019$3.28M-63.9%
FY2018Dec 31, 2018$9.10M-8.2%
FY2017Dec 31, 2017$9.91M+192.2%
FY2016Dec 31, 2016$3.39M-16.0%
FY2015Dec 31, 2015$4.04M+14.1%
FY2014Dec 31, 2014$3.54M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$26.96K-46.0%
Q1 FY2026Mar 31, 2026$31.59K-84.1%
Q4 FY2025Dec 31, 2025$36.55K-40.5%
Q3 FY2025Sep 30, 2025$34.63K-59.0%
Q2 FY2025Jun 30, 2025$49.95K-97.5%
Q1 FY2025Mar 31, 2025$198.58K-89.8%
Q4 FY2024Dec 31, 2024$61.43K-96.9%
Q3 FY2024Sep 30, 2024$84.53K-96.1%
Q2 FY2024Jun 30, 2024$1.97M-12.8%
Q1 FY2024Mar 31, 2024$1.94M-15.0%
Q4 FY2023Dec 31, 2023$1.98M-36.3%
Q3 FY2023Sep 30, 2023$2.16M-23.0%
Q2 FY2023Jun 30, 2023$2.25M-22.1%
Q1 FY2023Mar 31, 2023$2.29M-6.3%
Q4 FY2022Dec 31, 2022$3.11M-1.0%
Q3 FY2022Sep 30, 2022$2.80M-24.5%
Q2 FY2022Jun 30, 2022$2.89M-18.1%
Q1 FY2022Mar 31, 2022$2.44M-24.2%
Q4 FY2021Dec 31, 2021$3.14M-2.0%
Q3 FY2021Sep 30, 2021$3.71M+2.9%
Q2 FY2021Jun 30, 2021$3.53M+107.3%
Q1 FY2021Mar 31, 2021$3.22M+312.9%
Q4 FY2020Dec 31, 2020$3.21M+307.5%
Q3 FY2020Sep 30, 2020$3.60M+981.7%
Q2 FY2020Jun 30, 2020$1.70M+340.9%
Q1 FY2020Mar 31, 2020$780.00K-56.1%
Q4 FY2019Dec 31, 2019$787.00K-61.3%
Q3 FY2019Sep 30, 2019$333.00K-88.9%
Q2 FY2019Jun 30, 2019$386.00K-85.9%
Q1 FY2019Mar 31, 2019$1.78M+31.9%
Q4 FY2018Dec 31, 2018$2.04M-44.9%
Q3 FY2018Sep 30, 2018$2.99M+7.2%
Q2 FY2018Jun 30, 2018$2.73M+39.2%
Q1 FY2018Mar 31, 2018$1.35M-8.6%
Q4 FY2017Dec 31, 2017$3.69M+378.2%
Q3 FY2017Sep 30, 2017$2.79M+260.5%
Q2 FY2017Jun 30, 2017$1.96M–
Q1 FY2017Mar 31, 2017$1.47M–
Q4 FY2016Dec 31, 2016$772.00K–
Q3 FY2016Sep 30, 2016$773.00K–

More Vyome figures

See a number that looks wrong?